SCHEMBL3786186

SCHEMBL3786186

CC(=O)N[C@@H](CCS(C)(=O)=O)C(=O)O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
MAPT P10636 1/20 0.52
THRB P10828 1/20 0.52
ALOX15 P16050 1/20 0.52
NFKB1 P19838 1/20 0.52
PTGS2 P35354 1/20 0.52
THPO P40225 1/20 0.52
RECQL P46063 1/20 0.52
BLM P54132 1/20 0.52
KMT2A Q03164 4/20 0.51
ALDH1A1 P00352 4/20 0.50
TSHR P16473 2/20 0.49
GAA P10253 2/20 0.49
HSD17B10 Q99714 3/20 0.48
CYP1A2 P05177 1/20 0.47
CYP2C19 P33261 1/20 0.47
PLA2G2C Q5R387 1/20 0.47
MEN1 O00255 1/20 0.45
HTT P42858 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7439465 1.00 KDM4E (0.52) KDM4ESMN1; SMN2MAPTTHRBALOX15
SCHEMBL3787753 1.00 KDM4E (0.52) KDM4ESMN1; SMN2MAPTTHRBALOX15
SCHEMBL12052273 0.85 SMN1; SMN2 (0.52) KDM4ESMN1; SMN2MAPTTHRBALOX15
SCHEMBL203913 0.81 TGFBR1 (0.41) KDM4EKMT2AALDH1A1TSHRGAA
SCHEMBL2708048 0.81 TGFBR1 (0.41) KDM4EKMT2AALDH1A1TSHRGAA
SCHEMBL2707933 0.81 TGFBR1 (0.41) KDM4EKMT2AALDH1A1TSHRGAA
SCHEMBL12537175 0.81 TSHR (0.50) KDM4ESMN1; SMN2MAPTTHRBALOX15
SCHEMBL10076100 0.81 NOD1 (0.45) KMT2AALDH1A1TSHRPLA2G2CFOLH1
SCHEMBL11107976 0.80 PMP22 (0.38) KDM4EKMT2AALDH1A1TSHRGAA
SCHEMBL468726 0.79 MAPT (0.59) KDM4ESMN1; SMN2MAPTTHRBALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010126794-A1 METHODS FOR INCREASING GROWTH AND YIELD OF PLANTS WITH METHIONINE COMPOUNDS NOVUS INTERNATIONAL INC. (US) 2010-11-04 WO disclosed
EP-2001460-A2 COMPOSITIONS FOR PROMOTING HAIR GROWTH Novus International, Inc. (US) 2008-12-17 EP disclosed
WO-2007112433-A2 COMPOSITIONS FOR PROMOTING HAIR GROWTH NOVUS INTERNATIONAL INC. (US) 2007-10-04 WO disclosed
US-20070231377-A1 COMPOSITIONS FOR PROMOTING HAIR GROWTH NOVUS INTERNATIONAL INC. (US) 2007-10-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070231377-A1 COMPOSITIONS FOR PROMOTING HAIR GROWTH FGF1, MTR, HGF KDM4E 1133/4885SMN1; SMN2 3540/4885MAPT 464/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.